Works matching IS 17574676 AND DT 2012 AND VI 4 AND IP 8
Results: 15
Deleterious effects of neuronal accumulation of glycogen in flies and mice.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. 719, doi. 10.1002/emmm.201200241
- By:
- Publication type:
- Article
IGF2: The Achilles' heel of p53-deficiency?
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. 688, doi. 10.1002/emmm.201201509
- By:
- Publication type:
- Article
Masthead.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. n/a, doi. 10.1002/emmm.201290008
- Publication type:
- Article
Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. 691, doi. 10.1002/emmm.201200245
- By:
- Publication type:
- Article
Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. 791, doi. 10.1002/emmm.201101140
- By:
- Publication type:
- Article
SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. 776, doi. 10.1002/emmm.201100944
- By:
- Publication type:
- Article
Cholinergic-associated loss of hnRNP-A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. 730, doi. 10.1002/emmm.201100995
- By:
- Publication type:
- Article
p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. 808, doi. 10.1002/emmm.201101063
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. n/a, doi. 10.1002/emmm.201290007
- Publication type:
- Article
Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. 761, doi. 10.1002/emmm.201200244
- By:
- Publication type:
- Article
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. 675, doi. 10.1002/emmm.201101131
- By:
- Publication type:
- Article
DIAPH3 governs the cellular transition to the amoeboid tumour phenotype.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. 743, doi. 10.1002/emmm.201200242
- By:
- Publication type:
- Article
Telomerase gene therapy: a novel approach to combat aging.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. 685, doi. 10.1002/emmm.201200246
- By:
- Publication type:
- Article
Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. 705, doi. 10.1002/emmm.201101105
- By:
- Publication type:
- Article
A transcriptional network underlies susceptibility to kidney disease progression.
- Published in:
- EMBO Molecular Medicine, 2012, v. 4, n. 8, p. 825, doi. 10.1002/emmm.201101127
- By:
- Publication type:
- Article